Lyka Labs Limited (BOM:500259)
India · Delayed Price · Currency is INR 71.42
+0.18 (0.25%)
At close: Feb 4, 2026
Lyka Labs Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 1,289 | 1,336 | 1,051 | 883.39 | 1,836 | 671.07 |
Other Revenue | 13.35 | 13.35 | 10.51 | 10.78 | 8.82 | 14.04 |
| 1,302 | 1,349 | 1,062 | 894.17 | 1,845 | 685.11 | |
Revenue Growth (YoY) | 1.90% | 27.04% | 18.75% | -51.53% | 169.25% | 20.82% |
Cost of Revenue | 541.08 | 574.46 | 464.79 | 392.59 | 545.03 | 394.77 |
Gross Profit | 761.38 | 774.53 | 597.05 | 501.58 | 1,300 | 290.34 |
Selling, General & Admin | 424.7 | 385.55 | 295.71 | 204.02 | 194.64 | 155.61 |
Other Operating Expenses | 267.43 | 209.15 | 143.73 | 128.61 | 93.18 | -62.11 |
Operating Expenses | 770.24 | 662.18 | 567.46 | 474.1 | 461.32 | 176.74 |
Operating Income | -8.86 | 112.35 | 29.59 | 27.48 | 838.33 | 113.6 |
Interest Expense | -27.42 | -20.87 | -46.9 | -117.47 | -199.62 | -258.07 |
Interest & Investment Income | 4.63 | 4.63 | 8.62 | 21.54 | 13.41 | 11.06 |
Currency Exchange Gain (Loss) | 10.22 | 10.22 | 4.89 | 4.02 | 5.31 | 0.44 |
Other Non Operating Income (Expenses) | 19.89 | 5.14 | -1.43 | 6.67 | 0.23 | 2.61 |
EBT Excluding Unusual Items | -1.54 | 111.46 | -5.23 | -57.77 | 657.66 | -130.36 |
Impairment of Goodwill | -0.22 | -0.22 | - | - | - | - |
Gain (Loss) on Sale of Assets | - | - | - | - | - | 0.2 |
Asset Writedown | - | - | - | -0.78 | -24.11 | -10.15 |
Other Unusual Items | - | - | -4.11 | -73.16 | -41.08 | -1.13 |
Pretax Income | -1.75 | 111.25 | -9.34 | -131.71 | 592.47 | -141.44 |
Income Tax Expense | 1.66 | 31.92 | 16.87 | -0.19 | 208.04 | -40.53 |
Earnings From Continuing Operations | -3.41 | 79.33 | -26.21 | -131.53 | 384.43 | -100.91 |
Minority Interest in Earnings | -3.13 | 0.79 | 1.31 | -0.59 | 5.57 | -14.64 |
Net Income | -6.53 | 80.12 | -24.89 | -132.12 | 390 | -115.55 |
Preferred Dividends & Other Adjustments | 1.09 | 1.09 | 1.09 | 1.09 | 1.09 | 1.09 |
Net Income to Common | -7.62 | 79.03 | -25.98 | -133.2 | 388.91 | -116.63 |
Shares Outstanding (Basic) | 35 | 36 | 33 | 29 | 29 | 29 |
Shares Outstanding (Diluted) | 35 | 36 | 33 | 29 | 29 | 29 |
Shares Change (YoY) | -6.95% | 7.90% | 14.58% | 0.33% | - | 0.69% |
EPS (Basic) | -0.22 | 2.22 | -0.79 | -4.63 | 13.56 | -4.07 |
EPS (Diluted) | -0.22 | 2.22 | -0.79 | -4.63 | 13.56 | -4.07 |
Free Cash Flow | - | -137.55 | -74.58 | 7.67 | 717.33 | 75.44 |
Free Cash Flow Per Share | - | -3.87 | -2.26 | 0.27 | 25.00 | 2.63 |
Gross Margin | 58.46% | 57.42% | 56.23% | 56.09% | 70.45% | 42.38% |
Operating Margin | -0.68% | 8.33% | 2.79% | 3.07% | 45.45% | 16.58% |
Profit Margin | -0.58% | 5.86% | -2.45% | -14.90% | 21.08% | -17.02% |
Free Cash Flow Margin | - | -10.20% | -7.02% | 0.86% | 38.89% | 11.01% |
EBITDA | -26.54 | 157.11 | 157.61 | 168.95 | 1,012 | 196.84 |
EBITDA Margin | -2.04% | 11.65% | 14.84% | 18.89% | 54.85% | 28.73% |
D&A For EBITDA | -17.68 | 44.76 | 128.02 | 141.47 | 173.49 | 83.24 |
EBIT | -8.86 | 112.35 | 29.59 | 27.48 | 838.33 | 113.6 |
EBIT Margin | -0.68% | 8.33% | 2.79% | 3.07% | 45.45% | 16.58% |
Effective Tax Rate | - | 28.69% | - | - | 35.11% | - |
Revenue as Reported | 1,375 | 1,407 | 1,127 | 964.74 | 1,962 | 878.13 |
Advertising Expenses | - | 21.44 | 11.1 | 3.1 | 6.36 | 3.5 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.